Skip to main content
. 2022 Jan 7;17(8):1809–1813. doi: 10.4103/1673-5374.332155

Figure 2.

Figure 2

The effects of ta-VNS on cardiovascular measurements in acute stroke patients.

Measurements were taken every day for the 20 days of the experimental therapy. (A) HR, (B) SBP and (C) DBP. Data are expressed as mean ± SD and were analyzed by repeated-measures analysis of variance. DBP: Diastolic blood pressure; HR: heart rate; post: post-treatment; pre: pre-treatment; SBP: systolic blood pressure; ta-VNS: transcutaneous auricular vagus nerve stimulation.